US experts cautious about China’s new seaweed-based Alzheimer’s drug
digicomphoto/iStock(NEW YORK) -- Chinese regulators conditionally approved an Alzheimer's drug derived from seaweed, the world's first Alzheimer's drug in decades, according to drug maker Shanghai Green Valley Pharmaceuticals.The weekend news was met with cautious optimism by experts, who warned... Read More.